|
1
|
Choi KK, Kim MJ, Yun PY, Lee JH, Moon HS,
Lee TR and Myoung H: Independent prognostic factors of 861 cases of
oral squamous cell carcinoma in Korean adults. Oral Oncol.
42:208–217. 2006. View Article : Google Scholar
|
|
2
|
Xing Y, Qi J, Deng S, Wang C, Zhang L and
Chen J: Small interfering RNA targeting ILK inhibits metastasis in
human tongue cancer cells through repression of
epithelial-to-mesenchymal transition. Exp Cell Res. 319:2058–2072.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Yu ZW, Zhong LP, Ji T, Zhang P, Chen WT
and Zhang CP: MicroRNAs contribute to the chemoresistance of
cisplatin in tongue squamous cell carcinoma lines. Oral Oncol.
46:317–322. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Price KA and Cohen EE: Current treatment
options for metastatic head and neck cancer. Curr Treat Options
Oncol. 13:35–46. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Wingo PA, Tong T and Bolden S: Cancer
statistics, 1995. CA Cancer J Clin. 45:8–30. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Gu Y, Fan S, Xiong Y, Peng B, Zheng G, Yu
Y, Ouyang Y and He Z: Cloning and functional characterization of
TCRP1, a novel gene mediating resistance to cisplatin in an oral
squamous cell carcinoma cell line. FEBS Lett. 585:881–887. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Feng B, Wang R and Chen LB: Review of
miR-200b and cancer chemosensitivity. Biomed Pharmacother.
66:397–402. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Bartel DP: MicroRNAs: genomics,
biogenesis, mechanism, and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Filipowicz W, Jaskiewicz L, Kolb FA and
Pillai RS: Post-transcriptional gene silencing by siRNAs and
miRNAs. Curr Opin Struct Biol. 15:331–341. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Ansieau S, Morel AP, Hinkal G, Bastid J
and Puisieux A: TWISTing an embryonic transcription factor into an
oncoprotein. Oncogene. 29:3173–3184. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
da Silva SD, Alaoui-Jamali MA, Soares FA,
Carraro DM, Brentani HP, Hier M, Rogatto SR and Kowalski LP: TWIST1
is a molecular marker for a poor prognosis in oral cancer and
represents a potential therapeutic target. Cancer. 120:352–362.
2014. View Article : Google Scholar
|
|
12
|
Matsuo N, Shiraha H, Fujikawa T, Takaoka
N, Ueda N, Tanaka S, Nishina S, Nakanishi Y, Uemura M, Takaki A,
Nakamura S, Kobayashi Y, Nouso K, Yagi T and Yamamoto K: Twist
expression promotes migration and invasion in hepatocellular
carcinoma. BMC Cancer. 9:2402009. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Muniyappa H and Das KC: Activation of
c-Jun N-terminal kinase (JNK) by widely used specific p38 MAPK
inhibitors SB202190 and SB203580: a MLK-3-MKK7-dependent mechanism.
Cell Signal. 20:675–683. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Ding X, Zhang Z, Li S and Wang A:
Combretastatin A4 phosphate induces programmed cell death in
vascular endothelial cells. Oncol Res. 19:303–309. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Venugopal SK, Chen J, Zhang Y, Clemens D,
Follenzi A and Zern MA: Role of MAPK phosphatase-1 in sustained
activation of JNK during ethanol-induced apoptosis in
hepatocyte-like VL-17A cells. J Biol Chem. 282:31900–31908. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Liu M, Wang J, Huang H, Hou J, Zhang B and
Wang A: miR-181a-Twist1 pathway in the chemoresistance of tongue
squamous cell carcinoma. Biochem Biophys Res Commun. 441:364–370.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Zhan X, Feng X, Kong Y, Chen Y and Tan W:
JNK signaling maintains the mesenchymal properties of multi-drug
resistant human epidermoid carcinoma KB cells through snail and
twist1. BMC Cancer. 13:1802013. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Vasilevskaya I and O’Dwyer PJ: Role of Jun
and Jun kinase in resistance of cancer cells to therapy. Drug
Resist Updat. 6:147–156. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Rosenberg B, VanCamp L, Trosko JE and
Mansour VH: Platinum compounds: a new class of potent antitumour
agents. Nature. 222:385–386. 1969. View
Article : Google Scholar : PubMed/NCBI
|
|
20
|
Entz-Werlé N, Choquet P, Neuville A,
Kuchler-Bopp S, Clauss F, Danse JM, Simo-Noumbissie P, Guérin E,
Gaub MP, Freund JN, Boehm N, Constantinesco A, Lutz P, Guenot D and
Perrin-Schmitt F: Targeted Apc;Twist double-mutant mice: a new
model of spontaneous osteosarcoma that mimics the human disease.
Transl Oncol. 3:344–353. 2010. View Article : Google Scholar : PubMed/NCBI
|
